Lorazepam and Paraplatin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lorazepam (lorazepam) and Paraplatin (carboplatin). Common drug interactions include death among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Paraplatin. It is created by eHealthMe based on reports of 278 people who take the same drugs from the FDA, and is updated regularly.
What is Lorazepam?
Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.
What is Paraplatin?
Paraplatin has active ingredients of carboplatin. eHealthMe is studying from 12,392 Paraplatin users. Check the latest studies of Paraplatin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
278 people who take Lorazepam and Paraplatin together, and have interactions are studied.
What are the common drug interactions of Lorazepam and Paraplatin, by gender? *
What are the common drug interactions of Lorazepam and Paraplatin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lorazepam and Paraplatin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Lorazepam (165,639 reports)
- Paraplatin (12,392 reports)
Browse all drug interactions of Lorazepam and Paraplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lorazepam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Paraplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lorazepam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Paraplatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
- Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on lorazepam and carboplatin (the active ingredients of Lorazepam and Paraplatin, respectively), and Lorazepam and Paraplatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Fluoxetine cause Device Occlusion? - a second ago
- Could Profen cause Bone Pain Aggravated? - a second ago
- Could Prograf cause Pyelocaliectasis? - 3 seconds ago
- Drug interactions of Tequin and Dexamethasone - 4 seconds ago
- Drug interactions of Vitamin B and Allopurinol - 4 seconds ago
- Drug interactions of Divalproex and Flaxseed - 13 seconds ago
- Drug interactions of Dantrium and Pantoprazole - 13 seconds ago
- Could Lorazepam cause Cerebrovascular Disorder? - 13 seconds ago
- Drug interactions of Paracetamol and Viagra - 13 seconds ago
- Drug interactions of Lamictal and Magnesium - 16 seconds ago